Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

191 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Initial experience with introducing national guidelines for CT- and MRI-based delineation of organs at risk in radiotherapy.
Olsson C, Nyholm T, Wieslander E, Onjukka E, Gunnlaugsson A, Reizenstein J, Johnsson S, Kristensen I, Skönevik J, Karlsson M, Isacsson U, Flejmer A, Abel E, Nordström F, Nyström L, Bergfeldt K, Zackrisson B, Valdman A. Olsson C, et al. Among authors: valdman a. Phys Imaging Radiat Oncol. 2019 Sep 23;11:88-91. doi: 10.1016/j.phro.2019.08.006. eCollection 2019 Jul. Phys Imaging Radiat Oncol. 2019. PMID: 33458285 Free PMC article.
Comparing robust proton versus online adaptive photon radiotherapy for short-course treatment of rectal cancer.
Hundvin JA, Hege Lilleøren U, Valdman A, Sorcini B, Alfred Brennsæter J, Boer CG, Pettersen HES, Redalen KR, Marie Løes I, Pilskog S. Hundvin JA, et al. Among authors: valdman a. Phys Imaging Radiat Oncol. 2024 Nov 2;32:100663. doi: 10.1016/j.phro.2024.100663. eCollection 2024 Oct. Phys Imaging Radiat Oncol. 2024. PMID: 39559486 Free PMC article.
Preoperative short-course radiation therapy with PROtons compared to photons in high-risk RECTal cancer (PRORECT): Initial dosimetric experience.
Pedone C, Sorcini B, Staff C, Färlin J, Fokstuen T, Frödin JE, Nilsson PJ, Martling A, Valdman A. Pedone C, et al. Among authors: valdman a. Clin Transl Radiat Oncol. 2022 Dec 17;39:100562. doi: 10.1016/j.ctro.2022.100562. eCollection 2023 Mar. Clin Transl Radiat Oncol. 2022. PMID: 36582423 Free PMC article.
A national approach for automated collection of standardized and population-based radiation therapy data in Sweden.
Nyholm T, Olsson C, Agrup M, Björk P, Björk-Eriksson T, Gagliardi G, Grinaker H, Gunnlaugsson A, Gustafsson A, Gustafsson M, Johansson B, Johnsson S, Karlsson M, Kristensen I, Nilsson P, Nyström L, Onjukka E, Reizenstein J, Skönevik J, Söderström K, Valdman A, Zackrisson B, Montelius A. Nyholm T, et al. Among authors: valdman a. Radiother Oncol. 2016 May;119(2):344-50. doi: 10.1016/j.radonc.2016.04.007. Epub 2016 Apr 18. Radiother Oncol. 2016. PMID: 27102842
Proton Grid Therapy: A Proof-of-Concept Study.
Henry T, Ureba A, Valdman A, Siegbahn A. Henry T, et al. Among authors: valdman a. Technol Cancer Res Treat. 2017 Dec;16(6):749-757. doi: 10.1177/1533034616681670. Epub 2016 Dec 14. Technol Cancer Res Treat. 2017. PMID: 28592213 Free PMC article.
Development of a consensus-based delineation guideline for locally recurrent rectal cancer.
Piqeur F, Hupkens BJP, Nordkamp S, Witte MG, Meijnen P, Ceha HM, Berbee M, Dieters M, Heyman S, Valdman A, Nilsson MP, Nederend J, Rutten HJT, Burger JWA, Marijnen CAM, Peulen HMU. Piqeur F, et al. Among authors: valdman a. Radiother Oncol. 2022 Dec;177:214-221. doi: 10.1016/j.radonc.2022.11.008. Epub 2022 Nov 21. Radiother Oncol. 2022. PMID: 36410547
A Nordic-Baltic perspective on indications for proton therapy with strategies for identification of proper patients.
Brandal P, Bergfeldt K, Aggerholm-Pedersen N, Bäckström G, Kerna I, Gubanski M, Björnlinger K, Evensen ME, Kuddu M, Pettersson E, Brydøy M, Hellebust TP, Dale E, Valdman A, Weber L, Høyer M. Brandal P, et al. Among authors: valdman a. Acta Oncol. 2020 Oct;59(10):1157-1163. doi: 10.1080/0284186X.2020.1817977. Epub 2020 Sep 9. Acta Oncol. 2020. PMID: 32902341
191 results